Needham analyst Ryan MacDonald initiates coverage on Definitive Healthcare (NASDAQ:DH) with a Buy rating and announces Price Target of $30.
Unrivaled Brands FY22 Revenue Grows 23% To $52M, Here Are The Details
Unrivaled Brands, Inc. (OTCQB: UNRV) fiscal 2022 revenues increased $9.9 million, or 23%, from fiscal 2021, to $52.0 million. Revenue growth was driven primarily by a 63% increase in revenue from retail operations.
